| News and New Technologies from the Buyer's Guide for Life Scientists
|
Sponsored by DiagnoSwiss
ELISA in record time: GRAVI™-Cell
The novel miniaturized platform for manual processing of 8 parallel immunoassays within minutes is NOW AVAILABLE. The software driven and fully USB-powered GRAVI™-Cell instrument runs with micro-chip consumables. Units of GRAVI™-Chip, in which reactions and signal detection take place, are delivered in GRAVI™-Kit with required reagents (including ALP substrate). Assays are easily adapted to yield quantitative results over a broad dynamic range, with the additional benefit of lowest sample and reagent consumption.
more...
|
|
| Technology Spotlight |
 cDNA Synthesis For Real-Time PCR
Quantitative real-time RT-PCR (qRT-PCR) is a powerful tool for measuring gene expression which is rapidly replacing other methods such as the immunoassay, due to its ease, accuracy, and ability to multiplex. Real-time PCR< permits the quantification...
more...
|
|
| Product Focus |
Gel Documentation Systems
Although we refer to ‘gel documentation systems’ as such, this name doesn’t begin to cover the myriad of applications that today’s systems can handle. For gel documentation, these systems offer an array of options for visualizing...
more...
|
|
| News |
|
Critical Therapeutics Signs Definitive Agreement to Merge with Cornerstone BioPharma
more...
Wal-Mart Expanding Its Low-Priced Drug Program
more...
Genetic Engineering and Biotechnology News Reports on Early ADMET Use
more...
King Pharmaceuticals®, Inc. Announces Tilade Inhaler to be Discontinued
more...
Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
more...
FDA Concerned Over Wider Cephalon Pain Drug Use
more...
Pfizer Reaches Deal With Some Celebrex Users: Report
more...
Canary Foundation And The National Cancer Institute Launch New Prostate Cancer Study
more...
Consumers, Businesses, Unions, And Medical Professionals: Time For Congress To Act On E-Prescribing Legislation
more...
TorreyPines Therapeutics Licenses Intellectual Property From Johns Hopkins Related To Novel Uses Of Glutamate Receptor Antagonists For Prevention, Treatment Of Stroke, Heart Attack
more...
Lilly Oncology To Unveil More Than 50 Studies At ASCO 2008
more...
Abbott, Takeda Conclude TAP Joint Venture
more...
Novavax Opens Its First U.S. Vaccine Plant
more...
Merck & Co., Inc. (MRK) Receives Not Approvable Letter from FDA for MK-0524A (ER Niacin/laropiprant)
more...
Genentech, Inc. (DNA), Biogen Idec, Inc. (Massachusetts) (BIIB) Says Phase II/III Study of Rituxan Fails to Meet Endpoints
more...
Entelos Announces Agreement with Lilly
more...
Studies Shed Light on Risks of Commonly Used Drugs
more...
|
|
|
|
| Promotion |
Complimentary 2008-9 Catalog, Posters, iPod Nano Gift With Purchase
BioLegend is your one-stop source for optimal immunological reagents at an outstanding value. Visit our newly re-designed website at www.biolegend.com. Our 2008-9 Catalog contains 2,400+ new, innovative research tools and 8,000+ products, including new markers for Treg (FOXP3, FR4) and Th17 (IL-17A). Complimentary New Posters: Immunologic Networks and Updated Fluorochromes for Flow Cytometry and Microscopy. iPod Nano Gift: Purchase over $2,000 of reagents in a single order and receive a 4 GB iPod Nano (US customers, end users only, one per customer).
More Information
|
|
|
|
|
|
|
| Back to Top |
|
